Company intelligence / Profile preview

Shandong Zibo Xinda Pharmaceutical

Zibo, Shandong, Chinaxincat.com.cn ↗
Ownership
Private
Development stage
Other
01

Overview

Shandong Zibo Xinda Pharmaceutical is a Chinese pharmaceutical company specializing in the manufacture of generic antibiotics, including cephalosporins and penicillins. Its cefixime capsules have passed China’s generics consistency evaluation, confirming their quality and efficacy equivalence to branded products. The company is a wholly owned subsidiary of Shandong Xinhua Pharmaceutical Company Limited.

Therapeutic areas
PulmonologyGastroenterologyNephrologyInfectious Diseases
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

Compound Paracetamol and Amantadine Dispersible Tablets

Unknown

Beyond the preview

Go deeper on Shandong Zibo Xinda Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Zibo Xinda Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call